Mona Ashiya - Dec 12, 2023 Form 4 Insider Report for Disc Medicine, Inc. (IRON)

Role
Director
Signature
/s/ Mona Ashiya
Stock symbol
IRON
Transactions as of
Dec 12, 2023
Transactions value $
-$7,902,266
Form type
4
Date filed
12/14/2023, 05:40 PM
Previous filing
Jun 9, 2023
Next filing
Dec 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRON Common Stock Sale -$866K -14.4K -1.2% $60.16 1.18M Dec 12, 2023 See footnotes F1, F4
transaction IRON Common Stock Sale -$559K -9.3K -1.2% $60.16 764K Dec 12, 2023 See footnotes F2, F4
transaction IRON Common Stock Sale -$217K -3.6K -1.2% $60.16 296K Dec 12, 2023 See footnotes F3, F4
transaction IRON Common Stock Sale -$3.29M -56.2K -4.75% $58.56 1.13M Dec 13, 2023 See footnotes F1, F4
transaction IRON Common Stock Sale -$2.13M -36.4K -4.76% $58.56 728K Dec 13, 2023 See footnotes F2, F4
transaction IRON Common Stock Sale -$826K -14.1K -4.77% $58.56 282K Dec 13, 2023 See footnotes F3, F4
transaction IRON Common Stock Sale -$5.77K -100 -0.01% $57.73 1.13M Dec 14, 2023 See footnotes F1, F4
transaction IRON Common Stock Sale -$5.77K -100 -0.01% $57.73 728K Dec 14, 2023 See footnotes F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are held of record by OrbiMed Private Investments VIII, LP ("OPI VIII"). OrbiMed Capital GP VIII LLC ("GP VIII") is the general partner of OPI VIII and OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of GP VIII. The Reporting Person is an employee of OrbiMed Advisors. By virtue of such relationships, GP VIII and OrbiMed Advisors may be deemed to have voting power and investment power over the securities held by OPI VIII and as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares held by OPI VIII.
F2 These securities are held of record by OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Capital GP VI LLC ("GP VI") is the general partner of OPI VI and OrbiMed Advisors is the managing member of GP VI. By virtue of such relationships, GP VI and OrbiMed Advisors may be deemed to have voting power and investment power over the securities held by OPI VI and as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares held by OPI VI.
F3 These securities are held of record by OrbiMed Genesis Master Fund, L.P. ("Genesis"). OrbiMed Genesis GP LLC ("Genesis GP") is the general partner of Genesis and OrbiMed Advisors is the managing member of Genesis GP. By virtue of such relationships, Genesis GP and OrbiMed Advisors may be deemed to have voting power and investment power over the securities held by Genesis and as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares held by Genesis.
F4 Each of the Reporting Person, OrbiMed Advisors, GP VIII, GP VI, and Genesis GP disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of her or its pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Person, OrbiMed Advisors, GP VIII, GP VI, or Genesis GP is a beneficial owner of such securities for purposes of Section 16 of the Exchange Act, or for any other purpose.